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Bone marrow (BM) plays an important role in the long-term maintenance of memory T 
cells. Yet, BM is found in numerous bones throughout the body, which are not equal in 
structure, as they differ in their ratio of cortical and trabecular bone. This implies that BM 
cells within different bones are subjected to different microenvironments, possibly lead-
ing to differences in their frequencies and function. To address this, we examined BM 
from murine tibia, femur, pelvis, sternum, radius, humerus, calvarium, and the vertebrae 
and analyzed the presence of effector memory (TEM), central memory (TCM), and naïve 
(TNV) CD8+ T cells. During steady-state conditions, the frequency of the total CD8+ T cell 
population was comparable between all bones. Interestingly, most CD8+ T cells were 
located in the vertebrae, as it contained the highest amount of BM cells. Furthermore, 
the frequencies of TEM, TCM, and TNV cells were similar between all bones, with a majority 
of TNV cells. Additionally, CD8+ T cells collected from different bones similarly expressed 
the key survival receptors IL-7Rα and IL-15Rβ. We also examined BM for memory CD8+ 
T cells with a tissue-resident memory phenotype and observed that approximately half of 
all TEM cells expressed the retention marker CD69. Remarkably, in the memory phase of 
acute infection with the lymphocytic choriomeningitis virus (LCMV), we found a massive 
compositional change in the BM CD8+ T cell population, as the TEM cells became the 
dominant subset at the cost of TNV cells. Analysis of Ki-67 expression established that 
these TEM cells were in a quiescent state. Finally, we detected higher frequencies of 
LCMV-specific CD8+ T cells in BM compared to spleen and found that BM in its entirety 
contained fivefold more LCMV-specific CD8+ T cells. In conclusion, although infection 
with LCMV caused a dramatic change in the BM CD8+ T cell population, this did not 
result in noticeable differences between BM collected from different bones. Our findings 
suggest that in respect to CD8+ T cells, BM harvested from a single bone is a fair reflec-
tion of the rest of the BM present in the murine body.
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inTrODUcTiOn
The bone marrow (BM) acts as the primary site for the formation 
of all mature blood cells through the process of hematopoiesis. 
The complex hematopoietic process that gives rise to these cells 
takes place in the red (hematopoietic) part of the BM. At birth, 
BM primarily consists of red marrow, but with age, the red mar-
row decreases and is replaced by yellow (adipocytic) marrow 
(1). In adults (>25 years of age), red marrow is predominantly 
located in the tips (epiphysis), whereas yellow marrow is mostly 
found in the shafts (diaphysis) of the long bones. The epiphysis 
primarily consists of trabecular (spongy) bone, whereas the 
diaphysis consists of cortical (compact) bone (2). These differ-
ences in the composition of bone have been shown to influence 
the function of the BM. Human hematopoietic stem cells (HSCs) 
isolated from trabecular marrow of long bones have superior 
regenerative and self-renewal capacity compared to HSCs from 
the cortical marrow harvested from the shaft area and have also 
been shown to be molecularly distinct (3). Farrell et al. (4) found 
similar numbers of human HSCs and myeloid progenitor cells 
(GM-CFCs) in trochanter marrow (region between the epiphysis 
and diaphysis of the femur) compared to marrow in the femoral 
epiphysis. However, they observed a decline in numbers of 
femoral marrow-derived GM-CFCs in aged individuals, while 
the numbers for GM-CFCs derived from trochanter marrow did 
not change. In mice, substantial heterogeneity has been found 
in bone remodeling activity, blood volume fraction, and hypoxia 
between epiphysis, diaphysis, and calvarium, which were also 
shown to affect HSC function (5). These data indicate that distinct 
compartments within the BM are different, leading to functional 
differences for the cells that reside in these specific niches.
Next to its important function as a primary lymphoid organ, 
the BM has also gained recognition for its role as a secondary 
lymphoid organ. Dendritic cells in the BM can take up and present 
blood-borne antigens and thereby activate local naïve T cells (6). 
Neutrophils can capture and transport virus from the dermis into 
the BM, leading to priming of virus-specific CD8+ T cells by local 
antigen presenting cells (7). Additionally, the BM is also actively 
involved in immunological memory. Effector T cells that survive 
antigen clearance develop into memory T cells and home to the 
BM. Here, they provide life-long protection against reinfection 
(8–10). Studies in mice lacking IL-7 and IL-15 or their receptors 
IL-7Rα (CD127) and IL-15Rβ (CD122) have shown that these 
two cytokines are vital for the maintenance of memory CD8+ T 
cells, as they affect both their generation and survival (11–13). 
These effects could be direct, but they could also be mediated 
indirectly through the induction of costimulatory molecules 
that control memory T cell survival (14, 15). It has recently been 
shown that BM memory CD8+ T cells acquire IL-7 by docking to 
IL-7-producing reticular stromal cells (16). Additionally, human 
memory CD8+ T cells have been shown to be in close contact 
with a variety of IL-15-producing BM cells. These BM resident 
cells displayed morphological characteristics of stromal cells, 
dendritic cells, and monocytes (17).
Thus, it is now clear that BM is important for long-term 
memory maintenance and is therefore more frequently included 
in studies of (adaptive) immune responses [reviewed in Ref. (18, 
19)]. However, little is known about quantitative and qualitative 
differences between various bones regarding T cell mainte-
nance. Most information on BM T cells has been obtained from 
single cell suspensions prepared from crushed or flushed tibia 
and/or femurs. Hence, the BM has been conceptually and also 
practically regarded as a single organ. However, this view may 
not be justified, as bones throughout the body are diverse in 
their composition of cortical and trabecular bone depending 
on their mechanical or organ protection function (2), already 
leading to functional differences at the level of HSCs. Here, 
we examined if anatomical differences exist in BM, by assess-
ing the CD8+ T cell population in BM harvested from murine 
tibia, femur, pelvis, sternum, radius, humerus, calvarium, and 
vertebrae and compared this to the spleen. We found that both 
in steady state and after infection with acute lymphocytic cho-
riomeningitis virus (LCMV), BM located in distinct bones have 
comparable frequencies of CD8+ T cell subsets. Furthermore, 
by calculating the total number of BM CD8+ T cells found in 
the entire body, we demonstrate that BM is superior to spleen 
in harboring memory CD8+ T cells, and that this is attributed 
to the major contribution of the memory CD8+ T cells present 
in the vertebrae.
MaTerials anD MeThODs
Mice
Wild-type (WT) C57BL/6J mice were kept under specific 
pathogen-free conditions in the animal facility of the Academic 
Medical Center (Amsterdam, The Netherlands) or Netherlands 
Cancer institute (Amsterdam, The Netherlands). Female or male 
mice between the age of 13 and 17 weeks were used for steady-state 
experiments. For LCMV experiments, mice that were 9–16 weeks 
old were injected intraperitoneally with 2.0 ×  105  PFU of the 
Armstrong strain, kindly provided by Dr. Ramon Arens (LUMC, 
Leiden, The Netherlands) in 200 μl PBS. Mice were sacrificed dur-
ing the memory phase (>42 days post injection). Mice received 
chow and acidified drinking water ad  libitum. Animal experi-
ments were performed in accordance with the institutional and 
national guidelines and approved by the Experimental Animal 
Committees of both animal facilities.
sample collection and Preparation
Tibia, femur, pelvis, radius together with humerus were collected 
from every mouse. Additionally, we harvested sternum, calva-
rium, and the vertebrae (cervical vertebrae C1–sacral vertebrae 
S5). Bones were cleaned and crushed in MACS buffer (PBS + 1% 
FCS + 2 mM EDTA) using a mortar and pestle. BM cell suspen-
sions were filtered through a 40-μm cell strainer to remove bone 
debris. Single splenocyte suspensions were prepared by crushing 
the spleen through a 40-μm cell strainer with the plunger of a 
syringe. For several LCMV experiments, whole spleen and BM 
cells were enriched for CD8+ T cells with CD8α microbeads 
(Miltenyi Biotec) and MACS LS columns (Miltenyi Biotec). 
Erythrocytes were lysed with red blood cell lysis buffer (155 mM 
NH4Cl, 10 mM KHCO3, 127 mM EDTA). White blood cells were 
counted with CASY Cell Counter and Analyzer (Roche).
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Flow cytometry analysis
The following antibodies were used in this study: CD3ε-
eFlour 450 (145-2C11, eBioscience), CD3ε-APC-eFluor 780 
(17A2, eBioscience), CD8α-APC-eFluor 780 (53-6.7, eBiosci-
ence), CD8α-BV605 (53-6.7, Biolegend), CD8α-PerCP-Cy5.5 
(53-6.7, eBioscience), CD44-PE-Cy7 (IM7, Biolegend), 
CD62L-APC (MEL-14, eBioscience), CD62L-BV510 (MEL-
14, Biolegend), CD69eFluor 450 (H1.2F3, eBioscience) 
CD69-biotin (H1.2F3, eBioscience), CD122-FITC (TM-B1, 
BD Biosciences), CD127-BV605 (A7R34, Biolegend), and 
Streptavidin PerCP-Cy5.5 (BD Biosciences). The MHC class I 
tetramers H2-DbGP33–41 APC and H2-DbNP396–404 PE were kind 
gifts from Dr. Ramon Arens (LUMC, Leiden, The Netherlands). 
Cells were fixed with Foxp3/Transcription Factor Staining 
buffer set (eBioscience) and stained with Ki-67 PE or Ki-67 
FITC (B56, BD Biosciences). Samples were acquired with the 
LSR Fortessa (BD) and analyzed with FlowJo software (Tree 
Star, Inc.).
statistical analysis
Statistical analyses were performed with Prism (GraphPad 
Software, Inc.) using an unpaired t test followed by Welch’s cor-
rection or a one-way ANOVA followed by Tukey’s correction. 
Significance is indicated by *p < 0.05, **p < 0.01, ***p < 0.001, 
****p < 0.0001, and #p < 0.05 between spleen and all the different 
bones.
resUlTs
BM contains More Memory cD8+ T cells 
than the spleen
To examine whether the composition of the CD8+ T cell popula-
tion in a single bone is representative of all other bones, we exam-
ined the CD8+ T cells in BM from tibia, femur, pelvis, sternum, 
radius, humerus, calvarium, and vertebrae and compared this 
to the spleen. We observed that the frequencies of CD3+ cells, 
and also of CD8+ T cells, were significantly lower in all bones 
compared to the spleen (Figures 1A,B). Regarding the presence 
of the classical CD8+ T cell subsets, i.e., effector memory (TEM; 
CD44+CD62L−), central memory (TCM; CD44+CD62L+), and 
naïve (TNV; CD44−CD62L+) T cells (20, 21), we found that all 
bones consisted primarily (~65%) of TNV cells (Figures 1C,D). 
Strikingly, the frequencies of TEM, TCM, and TNV cells between 
the different bones were highly comparable. We observed that in 
comparison to spleen, all bones had higher frequencies of CD8+ 
TEM cells (Figure 1E). A similar pattern was observed for CD8+ 
TCM cells (Figure 1H). In absolute numbers, the majority of BM 
memory CD8+ T cells was located in the vertebrae (Figures 1F,I), 
as these contained the highest amount of BM cells, almost 
equivalent to the spleen (Table 1). BM, in its totality, contained 
~2.8-fold more TEM and ~1.5 more TCM cells compared to spleen 
(Figures 1G,J). Taken together, we conclude that in the steady 
state, BM is quite distinct from spleen regarding frequencies of 
CD3+ and CD8+ T cells, but comparable between the different 
bones. Additionally, we show that BM accumulates, also in abso-
lute numbers, more memory CD8+ T cells compared to spleen.
The expression of cD122 and cD127 on 
cD8+ T cells is similar between Different 
Bones
The cytokines IL-7 and IL-15 are important for the development 
and maintenance of BM CD8+ T cells (11–13). In the murine BM, 
the expression of these cytokines is primarily confined to stromal 
cells (22, 23). As bones differ in structure, and possibly also in 
composition of IL-7 and IL-15 producing stromal cells, we tested 
if BM CD8+ T cells regulate the expression of the IL-7 and IL-15 
receptors, according to their current location. This is particularly 
interesting, as IL-15 can regulate the expression of the receptor 
for IL-7 (24). Therefore, we compared the presence of CD122 and 
CD127 on CD8+ T cells collected from different bones. The high-
est expression of CD122 was found on the TCM cells, whereas TNV 
cells had the lowest expression of CD122 (Figure 2A). In contrast, 
TNV cells expressed the highest levels of CD127, while TEM cells 
expressed the lowest levels of CD127 (Figure 2E). Despite these 
marked differences in expression levels between the CD8+ T cell 
subsets, we observed similar expression of CD122 (Figures 2B–
D) and CD127 (Figures 2F–H) by CD8+ T cells harvested from 
different bones. It remains to be investigated whether the lack of 
anatomical differences in respect to receptor levels also reflects 
similar concentrations of IL-7 and IL-15 in BM in different bones.
BM effector Memory cD8+ T cells 
strongly increase after infection with 
lcMV
We did not observe differences in CD8+ T cell frequencies in 
BM collected from different bones in the steady state. Thus, we 
questioned whether this would change after an infection that 
elicits a large influx of memory T cells. Therefore, we infected 
mice with the Armstrong strain of LCMV. This acute systemic 
infection is cleared from the BM within 8 days due to a strong 
CD8+ T cell response (25, 26). We analyzed the BM in the mem-
ory phase (>42  days) and found that the frequencies of CD3+ 
cells and CD8+ T cells were lower when compared to the spleen, 
but still similar between bones (data not shown). Interestingly, 
we found that the frequency of the CD8+ TEM subset strongly 
increased, ranging from ~10% in the steady state to ~60% after 
LCMV (Figures 3A,B). The increase in TEM cells corresponded 
with a decrease in TNV cells, whereas the TCM subset was largely 
unaffected (Figures  3C–E). This was comparable between all 
bones. The TEM subset also increased in the spleen, although here 
the majority (~55%) of the CD8+ T cells still exhibited a naïve 
phenotype. Both BM and spleen TEM cells were primarily Ki-67−, 
indicating that they are in the G0 phase of cell cycle, and are thus 
resting memory CD8+ T cells (Figure 3F). This was similar for 
all the different bones (data not shown). In summary, we show 
that even after resolved infection with LCMV, no anatomical 
differences occur in the BM regarding CD8+ T cell frequencies.
BM contains cD8+ T cells with a Tissue-
resident Memory Phenotype
Apart from being a primary and secondary lymphoid organ, 
BM, like any other tissue, is susceptible to viral infections (27, 
FigUre 1 | comparable cD8+ T cell frequencies in BM obtained from different bones.  
 (Continued)
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TaBle 1 | BM yield from different bones.
absolute number of white blood cells (×106)
Steady state (n = 5)
Tibia 13.7 ± 8.0
Femur 25.3 ± 7.5
Pelvis 25.6 ± 10.1
Sternum 7.9 ± 2.6
Radius + humerus 14.4 ± 2.2
Calvarium 6.0 ± 2.0
Vertebrae 97.5 ± 16.9
Spleen 99.3 ± 9.9
White blood cell count per bone and spleen. Mean ± SD are shown (n = 5).
(a) Frequency of CD3+ and (B) CD8+ T cells in total white blood cells (WBC). (c) Representative FACS plots showing expression of CD44 and CD62L in CD8+ T 
cells for BM (radius + humerus) and spleen. (D) Frequency of TEM, TCM, and TNV cells within the total CD8+ T cell population. (e) Frequency and (F) absolute numbers 
of TEM cells within the total CD8+ T cell population. (g) Distribution of TEM cells (based on absolute numbers). (h) Frequency and (i) absolute numbers of TCM cells 
within the total CD8+ T cell population. (J) Distribution of TCM cells (based on absolute numbers). The double amount of cells was taken into account for estimating 
the contribution of tibia, femur, pelvis, and radius + humerus for the calculation of “Total BM” in (F,i) and for their contribution in (g,J). Graphs show mean ± SD of 
each bone (n = 4–8), pooled from the three independent experiments. Statistical analysis was performed with a one-way ANOVA followed by Tukey’s correction. 
Significance is indicated by *p < 0.05 or #p < 0.05 between spleen and all bones.
FigUre 1 | continued
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28). Interestingly, over the past few years, it has been reported 
that following an infection, a subset of memory CD8+ T cells 
has the ability to take up residence in a particular tissue and 
provide tissue-specific immunity. These tissue-resident memory 
T cells (TRM) have been identified in skin, female genital tract, 
intestinal mucosa, kidney, pancreas, stomach, heart, salivary 
glands, and the brain (29–34). These cells are characterized 
by the expression of the C-type lectin CD69, which inhibits 
the expression of the egress receptor sphingosine-1-phosphate 
receptor 1 (S1PR1) (35, 36). Moreover, TRM cells are identified 
by the absence of CD62L, making them a subgroup of the TEM 
subset (37). Here, we examined the expression of CD69 by 
BM TEM cells and compared these frequencies with the CD69 
expression in other BM CD8+ T cell subsets. We found that 
during the steady state, approximately half (~47%) of BM TEM 
cells and ~20% of BM TCM expressed CD69 (Figures  4A,B). 
The TNV subset barely expressed CD69 (data not shown). The 
frequencies of CD69 in each CD8+ T cell subset were similar 
for all bones (data not shown). Furthermore, the frequencies in 
the BM memory CD8+ T cells subsets were much higher than 
in the equivalent memory CD8+ T cell subsets located in the 
spleen (Figures 4A–D). Of specific note, after the infection with 
LCMV, the frequency of BM and spleen CD69+ cells decreased 
in the TEM subset, while the frequency of BM CD69+ cells in the 
TCM subset remained the same. However, we did not observe 
differences in absolute numbers of CD69+ TEM cells before 
and after infection (data not shown). This indicates that the 
decreased frequency of CD69+ TEM cells after infection results 
from a massive influx of CD69− TEM cells. In conclusion, BM 
contains a significant number of CD8+ T cells with a TRM phe-
notype, though an LCMV infection elicits an influx of mostly 
conventional TEM cells.
BM harbors a significant Portion of 
lcMV-specific cD8+ T cells
In order to analyze CD8+ T cells generated specifically against 
LCMV, we pooled BM from different bones to obtain sufficient 
cell numbers (26). BM from the vertebrae was analyzed separately 
because of its high cellularity. We enriched for CD8+ T cells and 
stained with MHC-I tetramers loaded with the LCMV epitopes 
GP33–41 and NP396–404. We observed that the spleen had lower fre-
quencies of LCMV-specific CD8+ T cells compared to either BM 
compartment (Figures  5A,D). We did not observe differences 
in frequencies of LCMV-specific CD8+ T cells between the BM 
from vertebrae and the other bones (Figures 5B,E). Based on the 
absolute numbers, the vertebrae itself contained ~35% of all GP33-
tetramer+ and 37% of all NP396-tetramer+ CD8+ T cells present in 
the total BM. Furthermore, as we harvested the majority of the 
BM from the body, we could calculate that BM harbored 1.5 × 105 
GP33-tetramer+ and 1.4 × 105 NP396-tetramer+ CD8+ T cells, which 
was fivefold to sixfold more than the spleen (Figures  5C,F), 
thereby emphasizing the role of the BM as memory T cell organ. 
LCMV-specific CD8+ T cells in BM primarily (~75%) had a 
TEM phenotype, while the remainder exhibited a TCM phenotype 
(Figure  5G). Additionally, LCMV-specific CD8+ T cells barely 
expressed CD69 or Ki-67, indicating that they were not actively 
cycling, but also not TRM cells (Figure 5H). Our results suggest 
that the distribution of LCMV-specific CD8+ T cells is comparable 
between BM in the vertebrae and the rest of the bones, and that 
these cells are phenotypically similar to the rest of the memory 
CD8+ T cells. Our data also suggest that infection with LCMV 
does not result in substantial generation of LCMV-specific CD8+ 
T cells with a TRM phenotype.
DiscUssiOn
In the present study, we examined BM from murine tibia, femur, 
pelvis, sternum, radius, humerus, calvarium, and vertebrae 
and addressed if anatomical differences exist at the level of BM 
CD8+ T cells. Here, we show that during the steady state, BM 
derived from different bones had similar CD8+ T cell frequencies. 
Furthermore, the frequencies of the TEM, TCM, and TNV subsets 
were also comparable between all the bones. We also examined 
BM during the memory phase of a LCMV infection. This virus 
is cleared primarily by CD8+ T cells and results in the generation 
of virus-specific memory CD8+ T cells, which remain detectable 
long after the initial infection (25, 26). Similarly to the steady 
state, we did not observe anatomical differences in BM after 
FigUre 2 | BM memory cD8+ T cell subsets differ in their expression of survival receptors. (a,e) Representative histograms showing expression of CD122 
and CD127 in CD8+ TEM, TCM, and TNV subsets. Black line indicates intensity of unstained cells. (B–D) MFI of CD122 or (F–h) MFI of CD127 on TEM, TCM, and TNV 
subsets. Dotted line indicates MFI of unstained cells. Graphs show mean ± SD for each bone (n = 5–8).
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FigUre 3 | The cD8+ T cell population consists primarily of memory cells after infection with lcMV. (a) Representative FACS plots showing expression of 
CD44 and CD62L in CD8+ T cells for BM (tibia) and spleen. (B) Frequency of TEM, TCM, and TNV subsets in CD8+ T cells. (c–e) Frequency of TEM, TCM, and TNV subsets 
in the CD8+ T cell population during steady state and after infection with LCMV. White bars = steady state and black bars = LCMV. Data for (c–e) are identical to 
that for Figure 1D and (B). (F) Representative FACS plots showing expression of Ki-67 on TEM cells in spleen and BM during steady state (femur) and after infection 
with LCMV (vertebrae). Graphs show mean ± SD of each bone (n = 4–8), pooled from the three independent steady states and the two independent LCMV 
experiments. Statistical analysis was performed with unpaired t test followed by Welch’s correction. Significance is indicated by *p < 0.05, ***p < 0.001, and 
****p < 0.0001.
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FigUre 4 | BM memory cD8+ T cell subsets contain cells that express cD69. (a,B) Representative histograms showing expression of CD69 on TEM or TCM 
cells in BM (femur) and spleen. (c,D) Frequency of CD69+ cells in the CD8+ TEM or TCM subsets in BM (vertebrae) and spleen. Graphs show mean ± SD of the 
vertebrae (n = 4–8), pooled from the three independent steady states and the two independent LCMV experiments. White bars = steady state and black 
bars = LCMV. Statistical analysis was performed with unpaired t test followed by Welch’s correction. Significance is indicated by **p < 0.01 and ****p < 0.0001.
January 2016 | Volume 6 | Article 6608
Geerman et al. BM CD8+ T Cells from Different Bones
Frontiers in Immunology | www.frontiersin.org
infection with LCMV. To date, only a limited number of studies 
have addressed the possible anatomical differences in the BM. 
These studies primarily focused on the functional differences 
within different regions inside a bone, but not necessarily between 
different bones. The majority of the studies found functional, but 
limited differences in frequencies of HSCs (3–5). It remains to be 
determined if BM T cells derived from different bones are also 
functionally distinct. Results obtained from a study performed 
with human BM suggest that this might not be the case. Pritz 
et al. (38) compared the phenotype and function of T cells derived 
from iliac crest and the femoral shaft and found no differences 
between the distribution of T cell populations and their cytokine 
production. Interestingly, although we found no differences 
between bones, we did observe that both during the steady state 
and after infection with LCMV, the majority of CD8+ T cells were 
located in the vertebrae, a collection of bones that has not been 
well studied and is not frequently included during sample prepa-
ration. From both a practical and ethical point of view, inclusion 
of the vertebrae can limit the amount of mice required for any 
given experiment, as it holds more than a third of all BM present 
in the murine body.
Here, we also demonstrated that BM substantially changes 
after infection with LCMV. The decline in frequency of TNV cells 
coincided with the increased frequency of TEM cells. As we did 
not observe differences in absolute numbers of total CD8+ T cells 
between steady state and LCMV-infected mice, our results sug-
gest that the space in the BM is limited, resulting in one subset 
being replaced by another. Sercan Alp et al. (16) demonstrated 
that memory CD8+ T cells colocalize with IL-7-producing 
reticular stromal cells, in a 1:1 ratio in the BM. This, combined 
with our results and the fact that CD8+ TNV cells primarily depend 
on IL-7 for survival [reviewed in Ref. (39)], suggests that CD8+ 
TNV cells were outcompeted or blocked from entering these 
IL-7-rich niches, as these became occupied by memory CD8+ T 
cells. Yet, we show that BM memory CD8+ T cells express the 
receptors to respond to both IL-7 and IL-15, which could indicate 
that naïve and memory CD8+ T cells reside in different niches. 
If this is indeed the case, our results suggest that after infection 
with LCMV, the BM microenvironment changed and became 
less favorable for naïve CD8+ T cells and/or a more advantageous 
for memory CD8+ T cells. As LCMV has been shown to infect 
BM stromal fibroblast and endothelial cells (27), it could well be 
that the cellular sources of IL-7 and IL-15 in the BM are severely 
affected by the infection. Alternatively, there could also be a role 
for hematopoietic cells, as dendritic cells can increase their IL-15 
production in response to inflammatory signals (40). Further 
studies are required to show how the BM niches that maintain 
CD8+ T cells adapt in order to accommodate the substantial 
amount of memory CD8+ T cells generated after infection with 
LCMV and how this relates to the spleen. Moreover, it remains 
unclear why the BM harbors so many TEM cells long after the 
infection has been resolved and whether their presence affects 
the hematopoietic function of the BM, as activated immune 
cells have been shown to directly influence HSC function and 
hematopoiesis [reviewed in Ref. (41)].
Furthermore, we demonstrated that BM contained CD8+ T 
cells with a TRM (CD44+CD62L−CD69+) phenotype. In the past, 
the surface molecule CD69 was associated with the “recently 
FigUre 5 | The frequency of lcMV-specific cD8+ T cells is similar between BM in vertebrae and the remaining bones. 
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(a) Representative FACS plots showing staining of GP33-tetramer in CD8+ T cells. (B) Frequency and (c) absolute numbers of GP33-tetramer+ cells in CD8+ 
T cells. (D) Representative FACS plots showing staining of NP396-tetramer in CD8+ T cells. (e) Frequency and (F) absolute numbers of NP396-tetramer+ cells in 
CD8+ T cells. (g) Representative FACS plots showing expression of CD44 and CD62L of GP33-tetramer+ or NP396-tetramer+ CD8+ T cells. (h) Representative FACS 
plots showing expression of CD69 and Ki-67 of GP33-tetramer+ or NP396-tetramer+ CD8+ T cells. For (g,h), tetramer+ cells (blue) are superimposed on all CD8+ T 
cells (gray). Percentages shown in (g,h) reflect the frequencies of tetramer+ CD8+ T cells. Graphs show mean ± SD of vertebrae or remaining BM (n = 3–6), pooled 
from the two independent experiments. Statistical analysis was performed with one-way ANOVA followed by Tukey’s correction or with unpaired t test followed by 
Welch’s correction. Significance is indicated by *p < 0.05, **p < 0.01, and ***p < 0.001.
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activated” status of T cells. More recently, this surface molecule 
has become important for its role in tissue retention, as it down-
regulates S1PR1 and thereby blocks the egress of lymphocytes 
from tissues (35). Currently, it is unclear if CD69 alone is suf-
ficient for identification of TRM cells in BM, as it has not been 
unequivocally demonstrated that CD69+ BM memory CD8+ T 
cells are non-circulating cells. Additionally, it has been postulated 
that TRM cells may reside in the CD69− fraction of memory T 
cells (42). Nonetheless, BM memory CD8+ T cells, which express 
CD69, resemble TRM cells in other tissues, as they have low 
expression of S1PR1 (16). Furthermore, in accordance with our 
findings, BM memory CD8+ T cells are not activated, but rather 
quiescent in terms of proliferation and gene expression (16). It 
is thus highly likely that the CD69+ memory CD8+ T cells that 
we identified in BM are resident, rather than recently activated 
T cells. Currently, it is understood that TRM cells reside in tissues 
where the initial infection took place and are positioned as the 
first line of defense, in order to accelerate pathogen elimination 
during secondary encounters (37). Whether TRM cells in the 
BM are also strategically positioned to fulfill a similar function 
and protect the BM from invading pathogens remains to be 
investigated.
In summary, our findings suggest that in respect to the 
frequency of CD8+ T cells, BM harvested from one bone is rep-
resentative of the BM found in all bones located throughout the 
body. Our results reinforce the notion that BM is a major immu-
nological organ, as it is quantitatively superior to the spleen in 
accumulation and accommodation of memory CD8+ T cells, and 
should therefore be included when studying (adaptive) immune 
responses and memory T cell maintenance.
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